Rentschler Company News

January 29, 2016

Article in BioProcess International

"The Single-Use or Stainless Steel Decision Process" read more

January 7, 2016

Rentschler appoints new Chief Executive Officer

Dr. Frank Mathias to become CEO of Rentschler Biotechnologie read more

December 15, 2015

Rentschler announces 4th Laupheim Biotech Days

The biennial scientific conference is taking place from June 13 to 14, 2016 read more

November 30, 2015

Participation in “PEGS Europe 2015”

Rentschler presented at one the most important protein therapeutics development and manufacturing meetings in Europe read more

October 7, 2015

Probiodrug and Rentschler sign manufacturing agreement

Probiodrug signs agreement with Rentschler for manufacture of its pGlu-Abeta targeting antibody PBD-C06 read more

October 2, 2015

Article in the European Biotechnology

"Value-adding perfusion-based biomanufacturing" read more

September 4, 2015

“The Seventh Annual Bioprocessing Summit” in Boston from 3rd to 7th August 2015

Rentschler presented expertise with process platforms and modular configured processes to express and purify therapeutic Proteins read more

June 22, 2015

Participation in “PEGS Summit 2015”

Rentschler presented at the essential protein engineering summit in Boston.  read more

Displaying news 1 to 10 out of 31

Rentschler Biotechnologie GmbH
Erwin-Rentschler-Str. 21
88471 Laupheim

Telefon: +49 - 7392 701-0
Telefax: +49 - 7392 701-300
E-Mail: info@rentschler.de

Web address of this page http://rentschler.de/en/information/news/